BLUE: bluebird bio, Inc. Stock

by  •  • Comments Off on BLUE: bluebird bio, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 40.63
Enterprise Value ($M) 65.49
Book Value ($M) -31.53
Book Value / Share -3.22
Price / Book -1.29
NCAV ($M) -337.10
NCAV / Share -34.43
Price / NCAV -0.12

Profitability (mra)
Return on Invested Capital (ROIC) -0.71
Return on Assets (ROA) -0.38
Return on Equity (ROE) -1.84

Liquidity (mrq)
Quick Ratio 0.28
Current Ratio 0.48

Balance Sheet (mrq) ($M)
Current Assets 154.67
Assets 460.23
Liabilities 491.77
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 83.81
Operating Income -267.70
Net Income -240.72
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -260.02
Cash from Investing 3.90
Cash from Financing 87.47

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Granahan Investment Management Inc/ma 0.00 -100.00
11-14 13G/A Alyeska Investment Group, L.P. 0.00 -100.00
11-13 13G/A Vanguard Group Inc 5.40 0.00
11-12 13G/A Goldman Sachs Group Inc 1.10 -81.99
11-08 13G BlackRock, Inc. 8.00 0.00
2024-04-10 13G/A State Street Corp 1.80 -75.28

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-09-27 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-09-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-09-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 34,619 117,866 29.37
2025-04-16 41,456 236,935 17.50
2025-04-15 74,198 261,322 28.39
2025-04-14 23,165 104,062 22.26

(click for more detail)

Similar Companies
BDTX – Black Diamond Therapeutics, Inc. BEAM – Beam Therapeutics Inc.
BIIB – Biogen Inc. BMEA – Biomea Fusion, Inc.
BMRN – BioMarin Pharmaceutical Inc.


Financial data and stock pages provided by
Fintel.io